Omnia SanaHerbal Remedies by Symptom
Cancer (anticancer research) - Medicinal Plants & Herbal Remedies
The Omnia Sana plant database documents 94 medicinal plants traditionally used for cancer (anticancer research). Each is rated by strength of evidence and linked to its full monograph and cited scientific sources.
Also known as: tumor, tumour, anticancer, anticancerous, antitumor, antitumour, cancerous, carcinoma, neoplasm, oncology, cancer support.
Boswellia serrata resin and its triterpenoid AKBA arrest the cell cycle and induce apoptosis in non-small-cell lung cancer, suppress colitis-associated colorectal cancer (NF-kB, gut microbiota) and inhibit prostate cancer (IL-17 pathway) in vitro and in vivo (preclinical).
Lemon verbena (Aloysia citrodora) essential oil and extracts show antiproliferative and pro-apoptotic activity against breast cancer and melanoma cells in vitro and reduce tumour growth in mouse models (targeting HB-EGF/EGFR and ERK signalling) (preclinical).
Althaea officinalis extract is chemoprotective against N-diethylnitrosamine-induced liver carcinogenesis, and marshmallow polysaccharides show documented anticancer activity (preclinical/chemopreventive).
A Calendula officinalis (LACE) aqueous extract inhibits proliferation (70-100%) of leukemia, melanoma, breast, prostate, lung and colon cancer cell lines via G0/G1 arrest and caspase-3 apoptosis and inhibits melanoma growth in nude mice; a systematic review documents its cytotoxic and antimetastatic antitumour activity (preclinical).
Acorus calamus extract inhibits gastric cancer (AGS) growth and angiogenesis; its constituent beta-asarone induces apoptosis and suppresses invasion/EMT in gastric, esophageal and bladder cancer cells and sensitizes them to chemotherapy (preclinical).
Garlic and its organosulfur compounds show broad preclinical anticancer/chemopreventive activity (apoptosis, cell-cycle arrest, anti-invasion); in the randomized Shandong Intervention Trial, 7 years of garlic supplementation significantly reduced gastric-cancer mortality over 22-year follow-up (preclinical + RCT).
Agrimonia eupatoria ethanolic extract shows dose-dependent cytotoxicity against MCF-7 (breast), HT-29 (colon), A549 (lung) and HeLa (cervical) cancer cells and inhibits the PI3K/Akt/mTOR/COX-2/MMP-2 axis (preclinical).
Aloe-emodin, an Aloe vera anthraquinone, induces apoptosis and inhibits growth of gastric, oral squamous, hepatocellular, lung (incl. xenograft) and glioblastoma cancer cells, modulating caspases, Bcl-2/Bax, PI3K/Akt and MEK/ERK signalling (preclinical).
Andrographolide (from Andrographis paniculata) acts as a chemopreventive and antitumour agent against breast, lung, colorectal, cervical, prostate and hepatocellular cancers and leukaemia, inducing apoptosis and inhibiting NF-kappaB and PI3K/AKT signalling (preclinical).
Angelica archangelica fruit tincture is antiproliferative against PANC-1 pancreatic cancer cells; its furanocoumarins imperatorin and xanthotoxin drive this activity and inhibit larynx cancer and rhabdomyosarcoma cell growth (preclinical).
Arnica montana and its constituent helenalin exert anticancer activity against several tumour types in vitro and in vivo, inhibiting NF-kappaB (p65) signalling, inducing apoptosis and synergizing with other anticancer agents (preclinical).
Astragalus membranaceus protects against gastrointestinal cancers; astragaloside IV inhibits lung cancer metastasis via macrophage repolarization, cycloastragenol boosts CD8+ T-cell antitumour immunity (with anti-PD-1 synergy), and Astragalus polysaccharide suppresses inflammation-induced colorectal cancer (preclinical).
The bearberry constituent arbutin suppresses osteosarcoma proliferation, migration and invasion via miR-338-3p/MTHFD1L and AKT/mTOR inactivation, and has documented anticancer potential against bladder, breast, colon, liver and other cancers (preclinical).
Polygonum bistorta (Bistorta officinalis) methanol-water and aqueous extracts inhibit hepatocellular carcinoma cells via ROS-induced ER stress and apoptosis (delaying xenograft tumour growth), with phenolic constituents driving the cytotoxicity (preclinical).
Ethanolic black cohosh extract inhibits growth of MCF-7 and MDA-MB-231 breast cancer cells; actein induces apoptosis/G1 arrest, inhibits breast, colon and HepG2 liver cancer cell growth and synergizes with doxorubicin, 5-FU, paclitaxel and simvastatin (preclinical).
inferred from preclinical anticancer/antiproliferative and antimutagenic activity
Anethum graveolens (dill) extract induces ROS-mediated apoptosis in HT-144 melanoma cells, and its essential oil is selectively cytotoxic and pro-apoptotic against A549 lung adenocarcinoma cells (preclinical).
Arctium lappa root reduces diet-induced preneoplastic colon lesions and suppresses melanoma progression; its lignan arctigenin induces apoptosis in colon (HT-29), breast (in vitro/in vivo), lung and gastric cancer cells and chemosensitizes them to doxorubicin (preclinical).
P. major extracts/compounds inhibited proliferation of cancer cell lines (preclinical).
Escin shows antiproliferative and pro-apoptotic activity and enhances chemotherapy/immunotherapy efficacy in breast (MCF-7), hepatocellular, lung and pancreatic cancer models; it modulates NF-kappaB, p53, p38 MAPK/ERK and PD-L1 (preclinical).
Alchemilla vulgaris extracts suppress the growth of MCF-7, A375, A549, HCT116 (aerial parts) and PC-3, MCF-7, Caco-2 (root) cancer cells via caspase-dependent apoptosis and autophagy, while protecting normal cells (preclinical).
Arctium minus extracts show dose-dependent cytotoxicity against MCF-7 and MDA-MB-231 breast cancer and HepG2 liver cancer cells and are active against both sensitive and multidrug-resistant tumour cell lines (preclinical).
Artemisia vulgaris (mugwort) extracts inhibit BCR/ABL and induce apoptosis in chronic myeloid leukaemia cells (including imatinib-resistant), and trigger tumour-selective ferroptosis/necroptosis in breast cancer and leukaemia cells via lysosomal Ca2+ signalling (preclinical).
Bacopaside II from Bacopa monnieri inhibits colon cancer cell growth via cell-cycle arrest and apoptosis (aquaporin-1 blockade), and its bacopasaponins are cytotoxic to lung (PC9) and colon (SW620) cancer cells (preclinical).
Artemisia absinthium (wormwood) total flavonoids (cynaroside, astragalin) inhibit HeLa cervical cancer cells via ROS-mediated apoptosis, and its terpenoid alpha,beta-thujone induces caspase-dependent apoptosis in choriocarcinoma cells and sensitizes them to paclitaxel (preclinical).
Antiproliferative activity of Achillea millefolium extracts and constituents (centaureidin, casticin) against HeLa, MCF-7 and A431 cancer cell lines (preclinical).
Educational information compiled from the Omnia Sana plant database. Not medical advice - always consult a qualified practitioner before using medicinal plants.